Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea on Mounjaro is one of the most commonly reported side effects, and the reason is rooted in how tirzepatide changes the way your gut works. The medicine slows digestion, shifts how your bowel responds to food, and activates receptors in the gut itself — a combination that, for many people, produces loose stools, urgency, or more frequent trips to the bathroom, especially in the early weeks. These are recognised side effects of Mounjaro listed in the medicine's patient information leaflet and confirmed in large clinical trials. They are also, for most people, temporary. A prescriber needs to assess whether tirzepatide is right for you before it can be supplied — it is a prescription-only medicine requiring clinical review.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) and the gut is full of them. One of the effects of stimulating these receptors is a significant slowing of gastric emptying: food moves from the stomach into the small intestine more slowly than your body is used to. That sounds like it should cause constipation, and for some people it does. But the picture is more complicated than that. The change in transit speed, combined with shifts in bile acid secretion and altered gut motility further down the digestive tract, can produce the opposite: loose stools, cramping, and urgency. The NHS medicines page for tirzepatide lists diarrhoea among the common side effects, alongside nausea, constipation, and indigestion, all part of the same underlying mechanism.
The bowel is also adjusting to a new hormonal environment. GLP-1 receptors line the intestinal wall, and activating them changes how the gut handles fluid and electrolytes. Some people experience watery stools for this reason alone. It is not a sign the medicine is unsafe or that your body is rejecting it. It is the gut responding to a real pharmacological change.
You can read a fuller breakdown of the specific mechanisms behind why Mounjaro causes diarrhoea if you want to understand the biology in more detail.
Yes, and this pattern is consistent across the trial data. Gastrointestinal side effects including diarrhoea tend to peak when you first start treatment and again after each dose increase, then gradually settle as your body adapts, often within two to three weeks, though the timeline varies. The SURMOUNT-1 trial, which involved thousands of adults treated with tirzepatide over 72 weeks, found GI events were most frequent early in treatment and declined over time for the majority of participants.
What you eat makes a difference too. Fatty, rich, or heavily processed foods are more likely to trigger symptoms, as is eating large portions, which runs counter to the appetite-reducing effect of the medicine anyway. Smaller meals, lower in fat, tend to be better tolerated. Alcohol can also worsen GI symptoms during treatment.
Timing matters practically as well. Some people find symptoms are more manageable if they keep their injection day consistent and plan for the day or two that follow. If your treatment started the week before Christmas or around a holiday, heavier eating patterns can make early side effects feel worse than they otherwise would, worth bearing in mind when you choose your first injection day.
For a closer look at the frequency and character of diarrhoea specifically on Mounjaro, including how it compares with other GI symptoms, our dedicated page covers this in full.
Loose stools that are inconvenient but short-lived are very different from symptoms that need urgent assessment. There are a few situations where you should contact your GP, prescriber, or 111 without waiting.
First: dehydration. If diarrhoea is frequent and you are struggling to keep fluids down (particularly alongside vomiting) your kidneys can come under strain quickly. Signs of dehydration include dark urine, dizziness, a dry mouth, and feeling faint. This needs clinical input, not just another glass of water.
Second: severe or escalating abdominal pain. Ordinary GI discomfort from tirzepatide tends to be mild to moderate and diffuse. Severe stomach pain that builds over hours, or pain that travels to the back, is a different matter entirely. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known but infrequent serious side effect of GLP-1 medicines, the signal was clear enough to warrant a formal safety communication. Pancreatitis can present with exactly this kind of pain, often with or without vomiting. Do not manage this at home.
Third: diarrhoea that does not settle. If you are wondering whether diarrhoea is something most people actually get on Mounjaro, the short answer is that it is common but not universal, and if it persists well beyond the first few weeks without improvement, that is worth discussing with your prescriber rather than tolerating indefinitely. Dose adjustments or additional support may be appropriate.
You can report unexpected or severe side effects directly through the MHRA Yellow Card scheme, which exists specifically so that patients and clinicians can flag safety signals in real time. It is a genuinely useful tool, not just a formality.
Most of the evidence for managing GI side effects in practice comes from the clinical teams running the SURMOUNT trials and from prescriber guidance built into NHS frameworks. The consistent advice is: eat smaller amounts, choose lower-fat foods, stay well hydrated, and avoid alcohol during the adjustment phase. There is no licensed anti-diarrhoeal medicine specifically recommended alongside tirzepatide, but your prescriber can advise whether something like loperamide is appropriate for short-term use in your case.
Spacing meals further apart can help. The stomach empties more slowly on tirzepatide, so eating before a previous meal has fully digested can compound GI symptoms. If you are trying to work out why you specifically are experiencing diarrhoea on Mounjaro, keeping a simple food diary for the first few weeks helps you identify patterns, specific foods or meal sizes that reliably cause problems.
Some people also find that the burping and reflux side effects ease alongside the diarrhoea once they settle into a different eating pattern. The gut adjustments are connected.
If you have questions about side effects and how they would be managed for you specifically, starting a free consultation with our prescribers is the right place. Side effect management is part of the clinical conversation, not an afterthought. Our prescribers are available for aftercare seven days a week, and you can read more about our clinical team and how the service is structured.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.